Back to Dashboard
PODD · Healthcare

Insulet Corp

USA Healthcare Filing: 2026-06-30
34/100
Smart-money confidence1 of 3 sources positive
Below average interest

No standout activity across the feeds we track.

What this band has actually done: stocks scoring 25–45 beat the S&P 500 over the next three months 45.3% of the time, across 39,662 cases since 2015. That is below a coin flip — and so is every other band, because the median stock loses to a cap-weighted index. How we measured this

Hedge funds
45
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s.  ·  how the score works
Market cap
$9.2B
Industry
Medical Devices
Sector
Healthcare
Exchange
NasdaqGS
About INSULET CORP

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes in the United States and internationally. The company offers Omnipod platform products comprising Omnipod 5 automated insulin delivery system, which includes a proprietary AID algorithm embedded in the pod that integrates with a third-party continuous glucose monitor to obtain glucose values through wireless Bluetooth communication; Omnipod DASH insulin management system that features a Bluetooth enabled pod that is controlled by a smartphone-like personal diabetes manager…

Who's behind the signal
Every informed buyer we can see on PODD, across all three feeds.
Hedge funds · 9
AQR Capital Management Increased +54%
Citadel Advisors Increased +419%
D.E. Shaw & Co Increased +219%
+3 more in the full breakdown below ↓
Insiders
No significant Form 4 insider activity in the window.
Congressional trades · 14 on record
Disclosures from 2018-03-02 to 2026-08-18
Trade date Member Chamber Action Amount
2026-08-18 Gilbert Ray Cisneros, Jr. · D-CA House Bought $1,001 - $15,000
2026-05-07 Tina Smith · D-MN Senate Sold $100,001 - $250,000
2026-04-29 Tina Smith · D-MN Senate Sold $100,001 - $250,000
2024-01-04 Markwayne Mullin · R-OK Senate Sold $1,001 - $15,000
2023-12-22 Markwayne Mullin · R-OK Senate Sold $1,001 - $15,000
2023-07-12 Daniel S. Goldman · D-NY House Sold $1,001 - $15,000
2023-04-10 Daniel S. Goldman · D-NY House Bought $1,001 - $15,000
2023-01-03 Markwayne Mullin · R-OK Senate Bought $1,001 - $15,000
2021-02-16 Peter Meijer · R-MI House Sold $15,001 - $50,000
2020-03-17 Tina Smith · D-MN Senate Sold $250,001 - $500,000
Show the other 4
Trade date Member Chamber Action Amount
2018-08-30 Tina Smith · D-MN Senate Sold $15,001 - $50,000
2018-08-30 Tina Smith · D-MN Senate Sold $250,001 - $500,000
2018-06-01 Tina Smith · D-MN Senate Sold $100,001 - $250,000
2018-03-02 Tina Smith · D-MN Senate Sold $100,001 - $250,000
Not a model pick — but on our radar. INSULET CORP isn't in the top-10 model right now, but 9 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
9
Investors
1
New positions
6
Increasing
1
Decreasing
1
Unchanged
Price History
Loading price data...
A member of Congress bought A member sold
Return: High: Low:

Markers sit on the transaction date the member disclosed, snapped to the nearest close on the chart. They are not the date the public found out — that came later, and the gap is its own page. Every marker is listed by name in the table above.

Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Portfolio Allocation
How much of each investor's portfolio is allocated to INSULET CORP
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell INSULET CORP or any security.

Get the Weekly Update

Every week, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime